Neurosigma Singapore News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neurosigma singapore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neurosigma Singapore Today - Breaking & Trending Today

NeuroSigma Announces HSA Approval of the Monarch eTNS System in Singapore

LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) NeuroSigma today announced approval of the Monarch eTNS System by Singapore’s Health Sciences Authority (HSA), the national body that regulates medical devices, therapeutics, and other healthcare products. The Monarch external Trigeminal Nerve Stimulation (eTNS) System is indicated for treatment of pediatric attention deficit hyperactivity disorder (ADHD) as a monotherapy for patients ages 7 through 12 years old who are not currently taking prescrip ....

United States , Los Angeles , Colin Kealey , C Thomas Paschall , Singapore Health Sciences Authority , Checkmate Capital Group , Health Sciences Authority , Trigeminal Nerve Stimulation , Neurosigma Singapore , Southeast Asia , George Clinical , Checkmate Capital , The Monarch , Regulatory Approval , Fda Approval , Nnounced Approval ,

NeuroSigma Establishes Singapore Subsidiary

NeuroSigma Establishes Singapore Subsidiary
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Colin Kealey , Tom Paschall , Los Angeles , Neurosigma Inc , Agency For Science , Singapore Health Sciences Authority , Biomedical Sciences Industry Partnership Office , Checkmate Capital Group , Drug Administration , Neurosigma Pte Ltd , Neurosigma Pte , Los Angeles Based , Neurosigma Singapore , Southeast Asia ,